Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 12/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 134.38 USD | -0.36% |
|
-0.65% | +53.86% |
| Market Cap | 8.77B 7.93B 7.32B 6.63B 12.51B 825B 12.88B 87.88B 34.92B 441B 32.92B 32.22B 1,403B | P/E 2026 * |
26.6x | P/E 2027 * | 665x |
|---|---|---|---|---|---|
| Enterprise Value | 8.19B 7.41B 6.84B 6.19B 11.68B 770B 12.03B 82.1B 32.63B 412B 30.76B 30.1B 1,311B | EV / Sales 2026 * |
14.5x | EV / Sales 2027 * | 34.1x |
| Free-Float |
97.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -0.36% | ||
| 1 week | -0.65% | ||
| Current month | -7.23% | ||
| 1 month | -7.25% | ||
| 3 months | -11.60% | ||
| 6 months | +34.45% | ||
| Current year | +53.86% |
| 1 week | 131.26 |  | 138.82 |
| 1 month | 126.39 | | 146.44 |
| Current year | 77 | | 160.81 |
| 1 year | 77 | | 160.81 |
| 3 years | 15.58 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 30/11/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 17/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 30/11/2008 |
Harold Selick
CHM | Chairman | 71 | 18/03/2014 |
William Waddill
BRD | Director/Board Member | 68 | 30/06/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/09/26 | Exercice | Chief Financial Officer | 175,887 | 0.2718% | ||
| 10/09/26 | Exercice | Chief Executive Officer | 21,834 | 0.0337% | ||
| 03/09/26 | Don | Chief Executive Officer | -510 | 0.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -0.65% | +58.37% | +767.53% | 8.77B | |
| +1.10% | -2.67% | +62.79% | +70.47% | 68.45B | |
| +1.28% | +8.71% | +13.96% | +95.16% | 61.31B | |
| +0.36% | -0.95% | +20.09% | +99.04% | 55.73B | |
| -0.96% | +7.41% | +10.20% | +108.91% | 47.51B | |
| -1.25% | +2.35% | +22.74% | +38.34% | 44.68B | |
| -2.41% | -0.73% | +167.89% | +794.72% | 38.14B | |
| +1.21% | -2.56% | +20.27% | +52.81% | 35.85B | |
| -0.87% | -2.89% | +79.60% | +63.96% | 33.05B | |
| -2.22% | +8.56% | -39.26% | +397.14% | 25.9B | |
| Average | -0.41% | +2.34% | +41.66% | +248.81% | 42B | |
| Weighted average by Cap. | -0.16% | +2.77% | +40.61% | +177.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 566M 512M 473M 428M 807M 53.23B 832M 5.67B 2.25B 28.46B 2.13B 2.08B 90.58B | 240M 217M 201M 182M 343M 22.59B 353M 2.41B 957M 12.07B 902M 882M 38.43B |
| Net income | 353M 319M 295M 267M 503M 33.17B 518M 3.54B 1.4B 17.73B 1.32B 1.3B 56.44B | 32.9M 29.75M 27.46M 24.86M 46.91M 3.09B 48.32M 330M 131M 1.65B 123M 121M 5.26B |
| Net Debt | -576M -521M -481M -435M -822M -54.17B -846M -5.77B -2.29B -28.96B -2.16B -2.12B -92.18B | -567M -513M -473M -429M -809M -53.32B -833M -5.68B -2.26B -28.5B -2.13B -2.08B -90.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/11/26 | US$134.38 | -0.36% | 542,899 |
| 11/11/26 | US$134.86 | -1.03% | 332,592 |
| 10/11/26 | US$136.26 | +0.26% | 528,491 |
| 09/11/26 | US$135.90 | +2.92% | 607,111 |
| 06/11/26 | US$132.04 | -2.38% | 972,945 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
